Asp-Val pairs a strongly acidic residue with a hydrophobic valine, offering insight into charge-hydrophobic interplay during early folding events. Researchers examine its hydrogen-bond potential and solvent behavior. The dipeptide aids studies of enzymatic specificity and protonation effects. Applications span structural modeling, peptide design, and biochemical mechanism studies.
CAT No: R2665
CAS No:13433-04-0
Synonyms/Alias:H-Asp-Val-OH;Asp-Val;13433-04-0;Aspartyl-Valine;l-aspartyl-l-valine;CHEMBL441685;CHEBI:73832;(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-3-methylbutanoic acid;L-Asp-L-Val;alpha-aspartylvaline;MFCD00037285;L-alpha-Asp-L-Val;L-alpha-aspartyl-L-valine;L-I+/--Aspartyl-L-valine;SCHEMBL3785072;(S)-3-Amino-4-(((S)-1-carboxy-2-methylpropyl)amino)-4-oxobutanoic acid;DTXSID001314995;HY-P4313;BDBM50188511;DA-74019;FA108008;CS-0653482;Q27144150;(2S)-2-[(2S)-2-AMINO-3-CARBOXYPROPANAMIDO]-3-METHYLBUTANOIC ACID;(S)-3-amino-4-((S)-1-carboxy-2-methylpropylamino)-4-oxobutanoic acid;
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More